Treatment of oral ranula in HIV-positive patient.


Journal

Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 30 08 2019
revised: 06 02 2020
accepted: 11 02 2020
pubmed: 10 4 2020
medline: 21 10 2021
entrez: 10 4 2020
Statut: ppublish

Résumé

HIV-associated salivary gland disease refers to the pathology in head and neck lesions such as ranula, salivary gland swelling, xerostomia, and benign lymphoepithelial cysts in the parotid gland. Here, we present a unique case of the ranula patient with HIV infection treated with OK-423 sclerotherapy. Case report: The patient was a 42-year-old Japanese male with a few months history of oral floor swelling. Computed tomography (CT) showed a low-density area limited within the right floor of the mouth. Magnetic resonance imaging (MRI) revealed a distinct T2-high intensity area localized on the same location. The puncture fluid was bloody mucus, and the cytology was no malignancy. We diagnosed a simple ranula. He was, however, found to be HIV-antibody positive at the examination before treatment by chance. He was referred to the department of infectious diseases and definitively diagnosed HIV infection by western blot. We chose OK-432 sclerotherapy because of its minimally invasive and the risk of HIV infecting medical staff. Two times OK-432 injection made the lesion disappear. Conclusion: The case indicated that OK-432 sclerotherapy could be effective for ranula related to HIV.

Identifiants

pubmed: 32269001
pii: S0385-8146(20)30040-7
doi: 10.1016/j.anl.2020.02.009
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-174

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Yusuke Kusano (Y)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Ryoukichi Ikeda (R)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Yutaro Saito (Y)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Muneharu Yamazaki (M)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Yutaka Tateda (Y)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Shiori Kitaya (S)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Fumi Shoji (F)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Takahiro Suzuki (T)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Naoya Noguchi (N)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Masafumi Seki (M)

Division of Infectious diseases and infection control, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.

Nobuo Ohta (N)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan. Electronic address: noohta@hosp.tohoku-mpu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH